Stock Detail
PHARMACEUTICAL COMPANIES
Drugs - Generic
PRX @ Yahoo Finance | PRX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $28.80 | $28.86 | $0.33 | 1.16% | 0.00 | $28.47 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $28.14 | $27.92 | 636,468 | 1.05B | 395,776.33 | -17.14 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 29.47 | 29.14 | 28.53 | 28.20 | 27.59 |
Stock Profile
Par Pharmaceutical Companies, Inc., a holding company, engages in the research, development, manufacture, and distribution of generic drugs in the United States. Its product line comprises generic prescription drugs consisting of 187 products representing various dosage strengths for 80 separate drugs. The company's generic drug products include central nervous system, cardiovascular, anti-inflammatory, gastrointestinal, and anti-infective treatments. Its products are manufactured principally in the solid oral dosage form consisting of tablets, caplets, and two-piece hard shell capsules. Par Pharmaceutical also distributes one oral suspension product and one product in the semisolid form of a cream. In addition, it designs and develops intermediate ingredients used in the production of finished products for the pharmaceutical industry. The company markets its products under the Par label primarily to wholesalers, retail drug store chains, managed health care providers, and distributors principally through its internal sales staff. Par Pharmaceutical Companies has research and development agreements with Advancis Pharmaceutical Corporation to develop and market a formulation of the antibiotic amoxicillin; Aveva Drug Delivery Systems, Inc. to market a clonidine transdermal patch, a generic version of Boehringer Ingelheim's Catapres TTS; with IntelliPharmaCeutics, Ltd. for the development of a generic, controlled release drug product for the United States market; and Nortec Development Associates, Inc. The company was formerly known as Pharmaceutical Resources, Inc. and changed its name to Par Pharmaceutical Companies, Inc. in May 2004. Par Pharmaceutical is headquartered in Spring Valley, New York.